Literature DB >> 8892136

Transcutaneous electrical nerve stimulation for the control of pain in musculoskeletal disorders.

A J Robinson1.   

Abstract

The literature on the use of transcutaneous electrical nerve stimulation (TENS) for pain control in several common musculoskeletal disorders is reviewed. The need for this review stems from apparently contradictory results of numerous studies designed to address the efficacy of electrical stimulation procedures for pain control. The focus of the review is on the efficacy of TENS in the management of low back pain syndromes. Other areas discussed include TENS use in arthritic conditions, soft tissue inflammatory disorders, and in postoperative pain following orthopaedic surgical procedures. Methodological strengths and weaknesses of TENS studies are emphasized in order to assist the reader in understanding the relative value of TENS studies which either support or refute the efficacy of electrical stimulation procedures for pain control.

Entities:  

Mesh:

Year:  1996        PMID: 8892136     DOI: 10.2519/jospt.1996.24.4.208

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  9 in total

1.  No effect of bipolar interferential electrotherapy and pulsed ultrasound for soft tissue shoulder disorders: a randomised controlled trial.

Authors:  G J Van Der Heijden; P Leffers; P J Wolters; J J Verheijden; H van Mameren; J P Houben; L M Bouter; P G Knipschild
Journal:  Ann Rheum Dis       Date:  1999-09       Impact factor: 19.103

2.  Acu-TENS and Postexercise Expiratory Flow Volume in Healthy Subjects.

Authors:  Shirley P C Ngai; Alice Y M Jones; Christina W Y Hui-Chan
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-06       Impact factor: 2.629

3.  Evaluation of Transcutaneous Electrical Nerve Stimulation as a Treatment of Neck Pain due to Musculoskeletal Disorders.

Authors:  Mikhled Maayah; Mohammed Al-Jarrah
Journal:  J Clin Med Res       Date:  2010-05-19

4.  Transcutaneous electrical nerve stimulation reduces exercise-induced perceived pain and improves endurance exercise performance.

Authors:  Ali H Y Astokorki; Alexis R Mauger
Journal:  Eur J Appl Physiol       Date:  2017-02-03       Impact factor: 3.078

5.  Late administration of high-frequency electrical stimulation increases nerve regeneration without aggravating neuropathic pain in a nerve crush injury.

Authors:  Hong-Lin Su; Chien-Yi Chiang; Zong-Han Lu; Fu-Chou Cheng; Chun-Jung Chen; Meei-Ling Sheu; Jason Sheehan; Hung-Chuan Pan
Journal:  BMC Neurosci       Date:  2018-06-25       Impact factor: 3.288

6.  Effects of transcutaneous electrical nerve stimulation in the Management of Post-Injection Sciatic Pain in a non-randomized controlled clinical trial in Nnewi, Nigeria.

Authors:  Uchenna Prosper Okonkwo; Sam Chidi Ibeneme; Ebere Yvonne Ihegihu; Afamefuna Victor Egwuonwu; Ikechukwu Charles Ezema; Adesina Fatai Maruf; Emmanuel Chiebuka Okoye; Olanrewaju Peter Ibikunle; Antoninus Obinna Ezeukwu
Journal:  BMC Complement Altern Med       Date:  2018-11-26       Impact factor: 3.659

7.  A pilot study on using acupuncture and transcutaneous electrical nerve stimulation (TENS) to treat knee osteoarthritis (OA).

Authors:  Kazunori Itoh; Satoko Hirota; Yasukazu Katsumi; Hideki Ochi; Hiroshi Kitakoji
Journal:  Chin Med       Date:  2008-02-29       Impact factor: 5.455

8.  The Effects of High-Frequency Transcutaneous Electrical Nerve Stimulation for Dental Professionals with Work-Related Musculoskeletal Disorders: A Single-Blind Randomized Placebo-Controlled Trial.

Authors:  Hye Rim Suh; Tae Hoon Kim; Gyeong-Soon Han
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-17       Impact factor: 2.629

9.  Acute electromyostimulation decreases muscle sympathetic nerve activity in patients with advanced chronic heart failure (EMSICA Study).

Authors:  Marc Labrunée; Fabien Despas; Philippe Marque; Thibaut Guiraud; Michel Galinier; Jean Michel Senard; Atul Pathak
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.